Human hyalohyphomycoses: A review of human infections due to Acremonium spp., Paecilomyces spp., Penicillium spp., Talaromyces spp., and Scopulariopsis spp.

Hasan, Nour

doi:10.1201/9780429402012-20

Cited by 1 publication

(4 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…( Table S2 ). These fungi cause superficial or localized infections in immunocompetent patients and invasive or disseminated infections in immunocompromised hosts [ 253 , 254 ].…”

Section: Fungal Infectionsmentioning

confidence: 99%

“…Routes of infection include inhaling aerosolized spores from the soil, polluted waters, and decaying organic materials, entering fungal spores through wounds or other minor skin injuries, and ingesting contaminated food products. Among the reported risk factors are the use of medication (immunosuppressors), underlying medical conditions (HIV/AIDS, autoimmune disorders, transplanted patients, neutropenia, malignancy, liver diseases, kidney diseases), trauma, burns, surgery, and the use of a central venous catheter [ 253 , 254 ].…”

Section: Fungal Infectionsmentioning

confidence: 99%

“…The most significant hyalohyphomycosis symptoms include anemia, arthralgia, cellulitis, encephalitis, mental confusion, cough, endophthalmitis, fever, hepatosplenomegaly, keratitis, lymphadenopathy, onychomycosis, osteomyelitis, peripheral edema, peritonitis, pneumonia, renal failure, sinusitis, and weight loss [ 252 , 254 ].…”

Section: Fungal Infectionsmentioning

confidence: 99%

“…Diagnosis is performed by elaborating a medical history, symptoms record, physical examinations, and lab tests (histopathology immunohistological staining, culture, and molecular identification from biopsy, blood, and skin) [ 253 , 254 ].…”

Section: Fungal Infectionsmentioning

confidence: 99%

See 3 more Smart Citations

Clinical Manifestations of Human Exposure to Fungi

Oliveira

Lisboa

et al. 2023

JoF

View full text Add to dashboard Cite

Biological particles, along with inorganic gaseous and particulate pollutants, constitute an ever-present component of the atmosphere and surfaces. Among these particles are fungal species colonizing almost all ecosystems, including the human body. Although inoffensive to most people, fungi can be responsible for several health problems, such as allergic fungal diseases and fungal infections. Worldwide fungal disease incidence is increasing, with new emerging fungal diseases appearing yearly. Reasons for this increase are the expansion of life expectancy, the number of immunocompromised patients (immunosuppressive treatments for transplantation, autoimmune diseases, and immunodeficiency diseases), the number of uncontrolled underlying conditions (e.g., diabetes mellitus), and the misusage of medication (e.g., corticosteroids and broad-spectrum antibiotics). Managing fungal diseases is challenging; only four classes of antifungal drugs are available, resistance to these drugs is increasing, and no vaccines have been approved. The present work reviews the implications of fungal particles in human health from allergic diseases (i.e., allergic bronchopulmonary aspergillosis, severe asthma with fungal sensitization, thunderstorm asthma, allergic fungal rhinosinusitis, and occupational lung diseases) to infections (i.e., superficial, subcutaneous, and systemic infections). Topics such as the etiological agent, risk factors, clinical manifestations, diagnosis, and treatment will be revised to improve the knowledge of this growing health concern.

show abstract

“…( Table S2 ). These fungi cause superficial or localized infections in immunocompetent patients and invasive or disseminated infections in immunocompromised hosts [ 253 , 254 ].…”

Section: Fungal Infectionsmentioning

confidence: 99%

Section: Fungal Infectionsmentioning

confidence: 99%